» Articles » PMID: 28432601

Neuropathic Pain: Central Vs. Peripheral Mechanisms

Overview
Date 2017 Apr 23
PMID 28432601
Citations 155
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: Our goal is to examine the processes-both central and peripheral-that underlie the development of peripherally-induced neuropathic pain (pNP) and to highlight recent evidence for mechanisms contributing to its maintenance. While many pNP conditions are initiated by damage to the peripheral nervous system (PNS), their persistence appears to rely on maladaptive processes within the central nervous system (CNS). The potential existence of an autonomous pain-generating mechanism in the CNS creates significant implications for the development of new neuropathic pain treatments; thus, work towards its resolution is crucial. Here, we seek to identify evidence for PNS and CNS independently generating neuropathic pain signals.

Recent Findings: Recent preclinical studies in pNP support and provide key details concerning the role of multiple mechanisms leading to fiber hyperexcitability and sustained electrical discharge to the CNS. In studies regarding central mechanisms, new preclinical evidence includes the mapping of novel inhibitory circuitry and identification of the molecular basis of microglia-neuron crosstalk. Recent clinical evidence demonstrates the essential role of peripheral mechanisms, mostly via studies that block the initially damaged peripheral circuitry. Clinical central mechanism studies use imaging to identify potentially self-sustaining infra-slow CNS oscillatory activity that may be unique to pNP patients. While new preclinical evidence supports and expands upon the key role of central mechanisms in neuropathic pain, clinical evidence for an autonomous central mechanism remains relatively limited. Recent findings from both preclinical and clinical studies recapitulate the critical contribution of peripheral input to maintenance of neuropathic pain. Further clinical investigations on the possibility of standalone central contributions to pNP may be assisted by a reconsideration of the agreed terms or criteria for diagnosing the presence of central sensitization in humans.

Citing Articles

Effectiveness of Pharmacopuncture for Neuropathic Dysfunction: Clinical Evidence and Potential Mechanism.

Kim J, Kim T, Goo B, Nam S Toxins (Basel). 2025; 17(2).

PMID: 39998100 PMC: 11860357. DOI: 10.3390/toxins17020083.


Targeting LncRNA-Vof16: A Novel Therapeutic Strategy for Neuropathic Pain Relief.

He X, Mauki D, Zhao X, Dai S, Yang H, Zheng Y CNS Neurosci Ther. 2025; 31(2):e70241.

PMID: 39981976 PMC: 11843576. DOI: 10.1111/cns.70241.


Advanced cancer perineural invasion induces profound peripheral neuronal plasticity, pain, and somatosensory mechanical deactivation, unmitigated by the lack of TNFR1. Part. 1: Behavior and single-cell in vivo electrophysiology.

Gutierrez S, Parker R, Parker R, Zhang M, Santi M, Ye Y Mol Pain. 2025; 21:17448069251314738.

PMID: 39921540 PMC: 11898231. DOI: 10.1177/17448069251314738.


Small Fibre Pathology in Fibromyalgia: A review.

Marshall A, Elshafei M, Preston F, Burgess J, Goodson N, Fallon N Pain Ther. 2025; .

PMID: 39806197 DOI: 10.1007/s40122-024-00696-1.


Modulation of pain sensitivity by Ascl1- and Lhx6-dependent GABAergic neuronal function in streptozotocin diabetic mice.

Hwang S, Rahman M, Go E, Roh J, Park R, Lee S Mol Ther. 2025; 33(2):786-804.

PMID: 39741412 PMC: 11852955. DOI: 10.1016/j.ymthe.2024.12.039.


References
1.
Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J . Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005; 114(1-2):29-36. DOI: 10.1016/j.pain.2004.12.010. View

2.
Gaudet A, Popovich P, Ramer M . Wallerian degeneration: gaining perspective on inflammatory events after peripheral nerve injury. J Neuroinflammation. 2011; 8:110. PMC: 3180276. DOI: 10.1186/1742-2094-8-110. View

3.
Sun S, Chen D, Lin F, Chen M, Yu H, Hou L . Role of interleukin-4, the chemokine CCL3 and its receptor CCR5 in neuropathic pain. Mol Immunol. 2016; 77:184-92. DOI: 10.1016/j.molimm.2016.08.006. View

4.
Woolf C, Shortland P, Coggeshall R . Peripheral nerve injury triggers central sprouting of myelinated afferents. Nature. 1992; 355(6355):75-8. DOI: 10.1038/355075a0. View

5.
Alexander G, van Rijn M, van Hilten J, Perreault M, Schwartzman R . Changes in cerebrospinal fluid levels of pro-inflammatory cytokines in CRPS. Pain. 2005; 116(3):213-219. DOI: 10.1016/j.pain.2005.04.013. View